This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
FDA panel backs birth control patch despite higher clot risks
An FDA reproductive health panel backed Johnson & Johnson Ortho Eura patch, finding it likely carries a higher risk of blood clots than older pills but should stay available for women who struggle with daily pill adherence. The panel noted the patch offers a useful option for younger or busy women, while urging updated labeling as data remain inconclusive.
MENTIONED IN THIS ARTICLE
Adelphi, Md
Johnson & Johnson
Food and Drug Administration
FDA
Michele Orza
George Washington University
J&j
New Brunswick
N.J
Jeff Christensen
Janssen